Thursday, 6 December 2012

Smart Drugs for dumb people, a brief description


Cognitive enhancers have been used to treat people with neurological or mental disorders, but there is a growing number of healthy, "normal" people who use these substances in hopes of getting smarter. Although there are many companies that make "smart" drinks, smart power bars and diet supplements containing certain "smart" chemicals, there is little evidence to suggest that these products really work. Results from different laboratories show mixed results; some labs show positive effects on memory and learning; other labs show no effects. There are very few well-designed studies using normal healthy people.
Some smart drugs can be found in health food stores; others are imported or are drugs that are intended for other disorders such as Alzheimer's disease and Parkinson's disease. There are many Internet web sites, books, magazines and newspaper articles detailing the supposed effects of smart drugs. There are also plenty of advertisements and mail-order businesses that try to sell "smart drugs" to the public. However, rarely do these businesses or the popular press report results that show the failure of smart drugs to improve memory or learning. Rather, they try to show that their products have miraculous effects on the brain and can improve mental functioning.
Smart drugs work by selectively enhancing your brain powers. Smart drugs allow you to exaggerate abilities you already have. They increase one or more brain neurotransmitters (cascading), increasing blood flow to the brain (flooding), increasing permeability of neurons membranes (plasticity), and some even go so far as to turn on smart genes (upgrading).
The medical name for smart drugs is nootropics, a term coined by psycho chemist Dr.Giurgea - the grandfather of modern smart drugs. His creation, Nootropil (Piracetam) is so inherently safe that it can be purchased without a prescription.
Many of the positive effects of cognitive enhancers have been seen in experiments using rats. For example, scientists can train rats on a specific test, such as maze running, and then see if the "smart drug" can improve the rats' performance. But it is difficult to see how many of these data can be applied to human learning and memory.
Baylor University researchers have discovered a molecule called PKR, which regulates how neurons interact in memory-related tasks. When the molecule is genetically suppressed, another immune molecule called gamma interferon steps in. The understudy molecule is much better at increasing communication between neurons and making memory more efficient. By finding a chemical inhibitor for the PKR molecule the team realised it could generate the memory boost without using genetic engineering. They found a molecule that did the trick, and it could be used to develop drugs to help Alzheimer's patients combat memory loss. Likewise it could be used by people who don't have Alzheimers to turbo-charge their memories.
Research show 10% of UK students admit to taking ‘cognitive enhancing’ drugs to help them concentrate, stay up late and complete deadlines on time. This rises to 16% among US students. Professor Barbara Sahakian, a psychiatrist at Cambridge University, told the Independent: “People are starting to think about drug testing. Some of the students who don’t use cognitive enhancers may demand it because they are concerned about cheating. Some admissions tutors are also concerned about it.”
Ritalin, usually prescribed for attention deficit disorder, and Modafinil, prescribed for narcolepsy, are some of the most favoured ‘performance enhancers’ named by the report of a joint Academies workshop into Human Enhancement and the Future of Work. These drugs are being chosen by students and academics alike because they do not produce extreme changes in mood that usually accompany recreational use, such as a ‘high’ or ‘rush’, and do not lead to obvious physical dependence.
A 2011 study found that modafinil reduces impulsive behaviour and improves cognitive flexibility in sleep-deprived doctors. Unlike caffeine, which in higher doses is accompanied by tremor and heart palpitations, this is not seen with Modafinil. However neuroscientist Jack K Lewis blogged on Huffington Post UK about the dangers of believing the promise of such 'wonder' drugs. There are serious ethical implications of enhancements like these being necessary for jobs or degrees. Enhancement could benefit employee efficiency and even work–life balance, but there is a risk that it will be seen as a solution to increasingly challenging working conditions, which could have implications for employee wellbeing.
The secondary effects of drugs that have been sold as smart drugs, carries more then just a health risk, though this practice has been utilized by drug companies to resell a unsuccessful drug. Early adopters of technology and pressurized students are finding them selves searching unethical sources on the Internet. While short term usage carries the possible 10% enhancement, the long term effects have not been studied. As recreational drugs are slowly being accepted in studies for post traumatic syndrome and other benefits. The slow rise of smart drugs will no doubt prove to be a underground success, as rising cost of tuition fees and little job opportunities will induced desperation. The fallout could be a society split into two with the enhanced group dominating...


Wednesday, 5 December 2012

Patent Trolls, a brief description on innovation Tax...


Patent troll is a pejorative term used for a person or company who conducts patent litigation against one or more alleged infringers in an aggressive or opportunistic manner, with no intention to manufacture or market the patented invention.
In 1999 Peter Detkin, a lawyer at Intel Corporation, was frustrated. Companies that had never produced a single semiconductor chip were suing his firm for a total of $15 billion for patent infringement. Detkin referred to his antagonists as "patent extortionists." Threatened with a libel suit, he toned it down to "patent trolls." Detkin was referring to fairy-tale trolls, like the ones in "Three Billy Goats Gruff," who live under the bridges and threaten those who try to cross them. His name for the companies stuck.
Patent trolls may buy patents cheaply from entities not actively seeking to enforce them. For example, a company may purchase hundreds of patents from a technology company forced by bankruptcy to auction its patents.
The cost of defending against a patent infringement suit, as of 2004, is typically $1 million or more before trial, and $2.5 million for a complete defense, even if successful. Because the costs and risks are high, defendants may settle even non-meritorious suits they consider frivolous for several hundred thousand dollars. The uncertainty and unpredictability of the outcome of jury trials also encourages settlement.
According to research recently published by Boston University School of Law, last year patent trolls won a cool $29 Billion. One of the most worrying findings of research in to patent trolls is that the mere threat of a suit is enough to induce fear and make creators pay up.
The average legal cost to defend a patent case is $420,000 for small and medium sized companies and $1.52 million for large companies. The average settlement costs are $1.33 million for small and medium companies and $7.27 million for large companies.
The study notes that the America Invents Act, which passed last year and led to the creation of the look at the 500 suits, added rules that make it harder for these patent monetizers to file complaints against several defendants at once.
The findings come as technology giants, including Apple, Google, and Microsoft, meet in Switzerland to discuss patent litigation reform at a roundtable with the U.N.'s International Telecommunication Union. It's a very relevant topic given that some of technology's biggest players are fighting over software patents in courts around the world.
Critics say patent trolls soak up money that could be used on research and development and pass on precious little of it to inventors. Their heavy-handed enforcement tactics appear to be a drag on the very companies that are putting new technology to work. Many believe the fear of being sued for infringing on obscure, often vague patents discourages companies from innovating.
The risk of paying high prices for after-the-fact licensing of patents they were not aware of, and the costs for extra vigilance for competing patents that might have been issued, in turn increases the costs and risks of manufacturing or worst stop production.
The idea of licensing patents isn't new. In 1895, an inventor named George B. Selden patented a gasoline-engine-driven carriage. Though he wasn't successful as an automobile manufacturer, he collected plenty of fees from manufacturers in the burgeoning car market. In 1911, his patent was challenged successfully by Henry Ford when an appeals court ruled that the engine then used in cars differed from Selden's version.
By purchasing many patents focused on one area, trolls are able to cite so many instances of possible infringement that it makes it harder and more expensive for the target company to defend the suit.
Their attorneys are only paid if they win the case. Legal costs for the NPEs are reduced, while the legal fees for target company they're sky-high.
The impact of patent trolls falls most heavily on companies that invest in exploring and creating new products and technology. The cost, this study suggests, is a kind of tax on innovation. What's more, researchers found that very little of the wealth lost by target companies was transferred to inventors. In most cases, the companies that were sued were already using the technology, which they had developed independently. The lawsuits came years after the patent application, suggesting that the patent trolls were waiting until the related product achieved success in its intended market before striking. The Boston University researchers concluded that patent trolls, for the most part, exploit weaknesses in patent law. By attacking companies that inadvertently infringe on vague patents, they stifle rather than promote innovation.
Sometimes the inventors are not able to commercialise their products and they cannot afford defending their patents. Then selling the patent to a patent troll may be a way to benefit from the invention, thus encouraging innovation and promoting science and technology. However, the patent trolls may both promote and stifle the development. Therefore, the laws and regulations should be carefully balanced between too little benefits for the inventors and between too stifling patent troll opportunities. If some patents are issued for too weak inventions, that is a different problem to be tackled separately.
The continued rise of the patent troll has the American Federal Trade Commission and the Department of Justice hosting a public forum in December to study the issue more closely. While further developments in technology go through the discovery phase, it is still likely to hit one or two infringement suits along the way towards production. The probable fallout is a country that has no means of manufacturing new products. Also competing countries will arrive at a technical solutions faster then a country that allows innovation to stifle. The resultant conclusion is a country thrown back into the stone age. While emerging sciences and technologies cross over so many disciplines, the law on ideas have closed its borders reducing progress to a slow crawl. If this modern Innovation tax was to continue further, one would guess the infringement suits would extend towards a dystopian nightmare...

Tuesday, 4 December 2012

Alcohol, a brief description


In chemistry, an alcohol is an organic compound in which the hydroxyl functional group (-OH) is bound to a carbon atom. In particular, this carbon center should be saturated, having single bonds to three other atoms.
The most commonly used alcohol is ethanol, C2H5OH, with the ethane backbone. Ethanol has been produced and consumed by humans for millennia, in the form of fermented and distilled alcoholic beverages. It is a clear flammable liquid that boils at 78.4 °C, which is used as an industrial solvent, car fuel, and raw material in the chemical industry. Alcoholic beverages, typically containing 5% to 40% ethanol by volume, have been produced and consumed by humans since pre-historic times. A 50% v/v (by volume) solution of ethylene glycol in water is commonly used as an antifreeze.
Alcohol intoxication (also known as drunkenness or inebriation) refers to the physiological state induced by the consumption of alcohol, when it builds up in the bloodstream faster than it can be metabolized by the liver. Some effects of alcohol intoxication are central to alcohol's desirability as a beverage and its history as the world's most widespread recreational drug. Common effects are euphoria and lowered social inhibitions. Other effects are unpleasant or dangerous because alcohol affects many different areas of the body at once and may cause progressive, long-term harm when consumed in excess.
Common symptoms of alcohol intoxication include slurred speech, euphoria, impaired balance, loss of muscle coordination (ataxia), flushed face, dehydration, vomiting, reddened eyes, reduced inhibitions, and erratic behavior. Sufficiently high levels of blood-borne alcohol will cause coma and death from the depressive effects of alcohol upon the central nervous system.
Alcohol is metabolized by a normal liver at the rate of about one ounce (one two-ounce shot of spirits, a normal beer, a regular sized glass of wine) every 90 minutes. Ethanol's acute effects are largely due to its nature as a central nervous system depressant, and are dependent on blood alcohol concentrations:
  • 20–99 mg/dL - Impaired coordination and euphoria
  • 100–199 mg/dL - Ataxia, poor judgement, labile mood
  • 200–299 mg/dL - Marked ataxia, slurred speech, poor judgement, labile mood, nausea and vomiting
  • 300–399 mg/dL - Stage 1 anaesthesia, memory lapse, labile mood
  • 400+ mg/dL - Respiratory failure, coma
As drinking increases, people become sleepy, or fall into a stupor. After a very high level of consumption, the respiratory system becomes depressed and the person will stop breathing. The most important thing for people who witness someone "passing out" from too much alcohol is to get them emergency medical treatment. Comatose patients may aspirate their vomit (resulting in vomitus in the lungs, which may cause "drowning" and later pneumonia if survived). CNS depression and impaired motor co-ordination along with poor judgement increases the likelihood of accidental injury occurring. It is estimated that about one third of alcohol-related deaths are due to accidents (32%), and another 14% are from intentional injury.
The long term effects of alcohol range from possible health benefits for low levels of alcohol (ethanol) consumption to severe detrimental effects in cases of chronic alcohol abuse. Some experts argue that the benefits of moderate alcohol consumption may be outweighed by other increased risks, including those of injuries, violence, fetal damage, certain forms of cancer, liver disease and hypertension. As the apparent health benefits of moderate alcohol consumption are limited for populations at low risk of heart disease, other experts urge caution because of the possibility that recommending moderate alcohol consumption may lead to an increased risk of alcohol abuse.
Genetically speaking, an estimated one out of three people in East Asian countries have an alcohol flush reaction, colloquially known as "Asian Glow", a condition where the body cannot break down ingested alcohol completely because it lacks the genetically coded enzyme that performs this function in the bodies of drinkers with "European" tolerance levels. This syndrome has been associated with an increased risk of esophageal cancer in those who drink. It has also been associated with lower than average rates of alcoholism, possibly due to its association with adverse effects after drinking alcohol.
To the contrary, around 80% of Asian people (less common in Thailand and India) have a variant of the gene coding for the enzyme alcohol dehydrogenase called ADH1B, and almost all Chinese and Korean people have a variant of the gene called ADH1C. These genes result in an alcohol dehydrogenase enzyme which converts alcohol to acetaldehyde with a much higher efficiency than other gene variants (40 to 100-fold in case of ADH1B). In about 50% of Asians, the increased acetaldehyde accumulation is worsened by another gene variant, the mitochondrial ALDH2 allele, which results in an inhibited acetaldehyde dehydrogenase enzyme, responsible for the breakdown of acetaldehyde. The result is that affected people may be better at metabolizing alcohol, often not feeling the alcohol "buzz" to the same extent as others, but show far more acetaldehyde-based side effects while drinking.
 Family, twin and adoption studies have shown that alcoholism definitely has a genetic component. In 1990, Blum et al. proposed an association between the A1 allele of the DRD2 gene and alcoholism. The DRD2 gene is the first candidate gene that has shown promise of an association with alcoholism.
A protein which controls our urge to eat is involved in alcohol addiction, researchers from the Scripps Research Institute have found. Peptide ghrelin, which is known to stimulate eating, is said to play a major role in alcohol addiction. The discovery points to new possibilities for designing drugs to treat alcoholism and other addictions. The discovery was made while studying the amygdala region of the brain. Amygdala is thought to be a key region in the transition to alcohol dependence, that is, a biological change from experiencing a pleasant sensation upon consumption of alcohol to the need to consume alcohol to relieve unpleasant, negative feelings due to the lack of its consumption.
Peptide ghrelin is best known for stimulating eating through its action on a receptor known as GHSR1A in the hypothalamus region of the brain. But scientists have found that gene defects in both ghrelin and the GHSR1A receptor were associated with severe cases of alcoholism in animal models. Alcoholic patients have higher levels of ghrelin peptide circulating in their blood compared to non-alcoholic patients. And, the higher the ghrelin levels, the higher the patients' reported craving for alcohol.
After a week, researchers examined neurons from alcohol-addicted and control rats (which were not given alcohol), when both ghrelin and ethanol were added. First, the scientists added ghrelin followed by ethanol. This resulted in an even stronger increase in GABAergic responses in these neurons. GABAergic is a neurotransmitter that contributes to alcohol intoxication and it makes a person get addicted to alcohol.
Both shared and different mechanisms involved in the effects of ghrelin and ethanol in the central nucleus of the amygdala. Importantly, there is a tonic ghrelin signal that appears to interact with pathways activated by both acute and chronic ethanol exposure. Perhaps scientists could find a way to block ghrelin's activity in this region, they could theoretically dampen or even turn off the cravings felt by alcoholics.

Controversially researchers at the Norwegian University of Science and Technology analysed earlier studies on the drug between 1966 and 1970. Patients were all taking part in alcohol treatment programmes, but some were given a single dose of LSD of between 210 and 800 micrograms. For the group of patients taking LSD, 59% showed reduced levels of alcohol misuse compared with 38% in the other group. This effect was maintained six months after taking the hallucinogen, but it disappeared after a year. Those taking LSD also reported higher levels of abstinence.
Despite prohibition and other schemes for stopping the alcohol trade, it is still a popular social activity today. In many ways the process of temporarily losing ones inhibitions could give someone courage to talk to the opposite sex. Although some argue the process of finding a suitable mate at a bar might not give best results for long term compatibility. But however you define Alcohol, it is still a drug that will probably hang around society for a long time...